Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD 36.86
-0.44 (-1.18%)
Apr 29, 2026, 4:08 PM HKT
HKG:3692 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 4,372 | 3,278 | 2,584 | 2,713 | Upgrade
|
| Depreciation & Amortization | - | 401.35 | 366.38 | 344.6 | 278.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -5.72 | -2.1 | -11.24 | -3.94 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 31.98 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -61.27 | -158.22 | -67.58 | -26.28 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 2.12 | 13.86 | - | Upgrade
|
| Stock-Based Compensation | - | 137.73 | 171.37 | 179.42 | 65.47 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -18.18 | 22.38 | 7.15 | 0.82 | Upgrade
|
| Other Operating Activities | - | -1,032 | -820.19 | -2.96 | -22.01 | Upgrade
|
| Change in Accounts Receivable | - | 62.67 | 341.76 | 90.45 | -549.35 | Upgrade
|
| Change in Inventory | - | -86.73 | -129.54 | -40.94 | -111.75 | Upgrade
|
| Change in Accounts Payable | - | 54.09 | -58.53 | -26.03 | 123.95 | Upgrade
|
| Change in Unearned Revenue | - | -19.24 | 13.37 | 2.9 | -173.49 | Upgrade
|
| Change in Other Net Operating Assets | - | 25.38 | 90.17 | -332.15 | 282.26 | Upgrade
|
| Operating Cash Flow | - | 3,862 | 3,116 | 2,741 | 2,577 | Upgrade
|
| Operating Cash Flow Growth | - | 23.93% | 13.69% | 6.37% | 7.80% | Upgrade
|
| Capital Expenditures | - | -221.96 | -219.6 | -272.82 | -460.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 23.96 | 10.96 | 21.1 | 54.77 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -302.97 | -142.93 | -19 | -15.16 | Upgrade
|
| Investment in Securities | - | -1,988 | 647.54 | -5,846 | -2,095 | Upgrade
|
| Other Investing Activities | - | 1,097 | 778 | 181.17 | 256.75 | Upgrade
|
| Investing Cash Flow | - | -1,392 | 1,074 | -5,935 | -2,259 | Upgrade
|
| Short-Term Debt Issued | - | 500 | 900 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3,877 | Upgrade
|
| Total Debt Issued | - | 500 | 900 | - | 3,877 | Upgrade
|
| Short-Term Debt Repaid | - | -500 | -900 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -4,204 | -18.96 | -42.49 | -12.29 | Upgrade
|
| Total Debt Repaid | - | -4,704 | -918.96 | -42.49 | -12.29 | Upgrade
|
| Net Debt Issued (Repaid) | - | -4,204 | -18.96 | -42.49 | 3,865 | Upgrade
|
| Issuance of Common Stock | - | 33.19 | 37.99 | 13.14 | 15.11 | Upgrade
|
| Repurchase of Common Stock | - | -33.69 | -114.87 | -76.62 | -57.97 | Upgrade
|
| Common Dividends Paid | - | -1,858 | -652.08 | -712.18 | -380.87 | Upgrade
|
| Other Financing Activities | - | -3.21 | -5.77 | - | -24.23 | Upgrade
|
| Financing Cash Flow | - | -6,066 | -753.7 | -818.14 | 3,417 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -62.43 | -122.36 | -40.57 | -79.29 | Upgrade
|
| Net Cash Flow | - | -3,658 | 3,314 | -4,053 | 3,655 | Upgrade
|
| Free Cash Flow | - | 3,640 | 2,897 | 2,468 | 2,117 | Upgrade
|
| Free Cash Flow Growth | - | 25.67% | 17.36% | 16.60% | 119.88% | Upgrade
|
| Free Cash Flow Margin | - | 29.69% | 28.67% | 26.31% | 21.31% | Upgrade
|
| Free Cash Flow Per Share | - | 0.61 | 0.48 | 0.42 | 0.35 | Upgrade
|
| Cash Interest Paid | - | 3.21 | 5.77 | - | - | Upgrade
|
| Cash Income Tax Paid | - | 807.17 | 589.58 | 324.03 | 319.44 | Upgrade
|
| Levered Free Cash Flow | - | 2,401 | 2,069 | 1,453 | 1,256 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,405 | 2,111 | 1,489 | 1,289 | Upgrade
|
| Change in Working Capital | - | 36.16 | 257.23 | -305.78 | -428.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.